항암화학요법을 받는 암환자의 말초신경병증과 우울
Chemotherapy-induced Peripheral Neuropathy and Depression in Cancer Patients
0
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
University, Seoul, Korea Purpose: The purpose of this study was to assess chemotherapy induced peripheral neuropathy (CIPN) and to examine the relationship between CIPN and depression. Methods: A purposive sample of 105 patients treated with chemotherapy were recruited in the cross-sectional survey design. Data were collected using self-report questionnaires. The instruments used were the Chemotherapy Induced Peripheral Neuropathy Assessment Tool (CIPNAT) and Hospital Anxiety Depression Scale (HADS). Results: The most frequent suffering symptom of CIPN was ‘tingling feeling in the hand and foot’. Of the motor symptoms, ‘muscle weakness’ was the most frequent symptom and ‘muscle or joint aches’ was the strongest suffering symptom of CIPN. The mean score for suffering of CIPN was 4.1. The mean score was 1.04 for depression and the prevalence was 48.5%. CIPN was significantly positively correlated with depression (r=.38, p<.001). The result of simple regression analysis revealed that CIPN was predictive of depression (R2=.136, p<.001). Conclusion: Based on the findings of this study, nursing intervention programs focusing on CIPN management and alleviating
Abstract
University, Seoul, Korea Purpose: The purpose of this study was to assess chemotherapy induced peripheral neuropathy (CIPN) and to examine the relationship between CIPN and depression. Methods: A purposive sample of 105 patients treated with chemotherapy were recruited in the cross-sectional survey design. Data were collected using self-report questionnaires. The instruments used were the Chemotherapy Induced Peripheral Neuropathy Assessment Tool (CIPNAT) and Hospital Anxiety Depression Scale (HADS). Results: The most frequent suffering symptom of CIPN was ‘tingling feeling in the hand and foot’. Of the motor symptoms, ‘muscle weakness’ was the most frequent symptom and ‘muscle or joint aches’ was the strongest suffering symptom of CIPN. The mean score for suffering of CIPN was 4.1. The mean score was 1.04 for depression and the prevalence was 48.5%. CIPN was significantly positively correlated with depression (r=.38, p<.001). The result of simple regression analysis revealed that CIPN was predictive of depression (R2=.136, p<.001). Conclusion: Based on the findings of this study, nursing intervention programs focusing on CIPN management and alleviating
참고문헌 (26)
- Wolf S, "Chemotherapy-induced peripheral neuropathy : prevention and treatment strategies", Eur J Cancer, 44(11), pp.1507~1515 (2008)
- Andreas A. Argyriou, "Chemotherapy-induced peripheral neurotoxicity (CIPN): An update", Critical Reviews in Oncology, 2012, pp.82(1), 51~77[DOI]
- Hausheer FH, "Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy", Semin Oncol, 33(1), pp.15~49 (2006)
- Tofthagen CS, "Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool", Cancer Nurs, 34(4), pp.10~20 (2011)
- Windebank AJ, "Chemotherapy-induced neuropathy", J Peripher Nerv Syst, 13(1), pp.27~46 (2008)
- Gedge D. Rosson, "Chemotherapy-Induced Neuropathy", Clinics in Podiatric Medicine and Surgery, 23(3), pp.637~649 (2006), Elsevier BV[DOI]
- 김정혜, "신경독성 항암제를 투여받고 있는 암환자의 말초신경병증 증상과 일상생활 방해정도", Asian Oncology Nursing, 13(3), pp.145~151 (2013), 대한종양간호학회
- Hwang WH, "Assessment using CIPNAT for peripheral neuropathy in cancer patients undergoing chemotherapy", master, pp.2013
- 곽미경(Kwak, Mi Kyong), "항암화학요법으로 인한 암환자의 말초신경병증 관련 특성과 삶의 질", Asian Oncology Nursing, 10(2), pp.231~239 (2010), 대한종양간호학회
- 김혜영, "유방암 환자의 항암화학요법으로 인한 말초신경병증과 삶의 질", Asian Oncology Nursing, 13(4), pp.222~230 (2013), 대한종양간호학회
- Montgomery GH, "Pre-surgery distress and specific response expectancies predict post-surgery outcomes in surgery patients confronting breast cancer", Health psychol, 23(4), pp.381~387 (2004)
- 이세영, "발반사요법이 항암화학요법 관련 말초신경병증, 증상 디스트레스, 불안 및 우울에 미치는 효과", Asian Oncology Nursing, 12(4), pp.305~313 (2012), 대한종양간호학회[DOI]
- Faul F, "G*Power 3 : A flexible statistical power analysis program for the social, behavioral, and biomedical sciences", Behav Res Methods, 39(2), pp.175~191 (2007)
- Tofthagen CS, "Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool", Cancer Nurs, 34(4), pp.10~20 (2011)
- Oh SM, "A comparison of normal, depressed and anxious groups : A study on the standardization of the hospital anxiety and depressed scale for Koreans", J Korean Neuropsychiatr Assoc, 38(2), pp.289~296 (1999)
- Kim HM, "Symptoms and relief therapy related to chemotherapy induced peripheral neuropathy in patients with cancer", pp.2012
- 박애령, "진행성 또는 전이성 위암 환자에 있어서 Oxaliplatin 투여로 인한 말초신경통증 분석", 한국임상약학회지, 19(1), pp.18~22 (2009), 한국임상약학회
- Speck RM, "Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients", Support Care Cancer, 20(10), pp.2433~2439 (2012)
- Visovsky C, "Putting evidence into practice : evidence-based interventions for chemotherapyinduced peripheral neuropathy", Clin J Oncol Nurs, 11(6), pp.901~913 (2007)
- Pietrangeli A, "Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up", Eur Neurol, 56(1), pp.13~16 (2006)
- Ostchega Y, "High-dose cisplatin-related peripheral neuropathy", Cancer Nurs, 11(1), pp.23~32 (1988)
- Lee IH, "Easy Flow regression analysis", pp.313~316 (2014), Hannarae
- Cohen J, "Statistical power analysis for the behavioral sciences" (1988), Erlbaum
- Cappiello M, "Breast cancer survivors", Clin Nurs Res, 16(4), pp.278~293 (2007)
- Baek YA, "The correlation among symptoms, anxiety, depression and quality of life in patients with colorectal cancer undergoing chemotherapy", master, pp.2013
- So WK, "The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer : A multicenter study", Oncol Nurs Forum, 36(4), pp.205~214 (2009)